PHOENIX SECRETOMICS Human Cripto, also known as CFC-2 or TDGF-1 (teratocarcinoma-derived growth factor), was originally isolated from an undifferentiated human teratocarcinoma cell line as a potential oncogene. It is overexpressed in many types of cancers and acts as a growth factor for tumors. Preferentially expressed in gastric and colorectal carcinomas than in their normal counterparts. Human Cripto 188 amino acid, MW 21169 Da |
10 20 30 40 50 60
MDCRKMARFS YSVIWIMAIS KVFELGLVAG LGHQEFARPS RGYLAFRDDS IWPQEEPAIR
70 80 90 100 110 120
PRSSQRVPPM GIQHSKELNR TCCLNGGTCM LGSFCACPPS FYGRNCEHDV RKENCGSVPH
130 140 150 160 170 180
DTWLPKKCSL CKCWHGQLRC FPQAFLPGCD GLVMDEHLVA SRTPELPPSA RTTTFMLVGI
CLSIQSYY 188 |
  |
| Immunofluorescence staining of methanol-fixed F9 cells showing cell surface localization. Western blot analysis of Cripto in F9 cells. |
 |
| specices | sample | Range | Catalog No. | Quantity |
Price |
|
| Cripto ELISA Kit | human | cell culture supernate | 62.5 - 4000 pg/ml | PS001-41-EK-H-01 | 96 T |
400 |
| Antibody Name | Application | Specices | Host | Catalog No.: | Size |
Price |
| Cripto N-Terminal Antibody | WB(1: 200), FIC(1: 100) | m, r | goat | PS001-41-AG-01 | 50 ug |
240 |
| Cripto Monoclonal Antibody | WB, IHC, FC | human | mouse | PS001-41-MAG-01 | 50 ug |
240 |